IN VITRO RESPIRABLE PERFORMANCE OF AMIKACIN DRY POWDER VERSUS AMIKACIN NEBULIZATION

被引：0
|
作者：
Balducci, Anna Giulia [1 ,2 ]
Borella, Fabio [1 ]
Bettini, Ruggero [3 ]
Colombo, Paolo [3 ]
Buttini, Francesca [3 ]
机构：
[1] PlumeStars Srl, Via Lago Scuro 11, Parma, Italy
[2] Univ Parma, Interdept Ctr, Biopharmanet TEC, Parco Area Sci 27-A, I-43100 Parma, Italy
[3] Univ Parma, Dept Pharm, Parco Area Sci 27-A, I-43100 Parma, Italy
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2016年 / 29卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
73
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [1] Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance
    Shrenik P. Shah
    Ambikanandan Misra
    AAPS PharmSciTech, 5
  • [2] Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance
    Shah, SP
    Misra, A
    AAPS PHARMSCITECH, 2004, 5 (04)
  • [3] FORMULATING AMIKACIN FOR DRY POWDER INHALATION
    Sibum, I.
    Grasmeijer, F.
    Hagedoorn, P.
    Frijlink, H. W.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (02) : A7 - A7
  • [4] RESPIRABLE AMIKACIN DRY POWDERS FOR INHALATION BY QUALITY BY DESIGN PROCEDURE
    Belotti, S.
    Rossi, A.
    Colombo, P.
    Bettini, R.
    Rekkas, D.
    Politis, S.
    Colombo, G.
    Balducci, A. G.
    Buttini, F.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (04) : A9 - A9
  • [5] CEFTRIAXONE AND AMIKACIN VERSUS CEFTAZIDIME AND AMIKACIN IN FEBRILE GRANULOCYTOPENIA
    SCHMID, L
    JESCHKO, M
    WILDERSMITH, C
    SCHAFROTH, U
    THURLIMANN, B
    PEDRAZZINI, A
    SENN, H
    CHEMOTHERAPY, 1991, 37 (05) : 346 - 352
  • [6] AMIKACIN PLUS CEFTAZIDIME VERSUS AMIKACIN PLUS PIPERACILLIN VERSUS AMIKACIN PLUS AZTREONAM IN INFECTIONS IN NEOPLASTIC PATIENTS WITH GRANULOCYTOPENIA
    CASALI, A
    AMEGLIO, F
    GIONFRA, T
    TONACHELLA, R
    PAOLETTI, G
    CURCIO, CG
    CHEMIOTERAPIA, 1987, 6 (06): : 440 - 444
  • [7] MOXALACTAM AMIKACIN VERSUS TICARCILLIN AMIKACIN IN GRANULOCYTOPENIC PATIENTS - REPLY
    DEJONGH, CA
    WADE, JC
    SCHIMPFF, SC
    AMERICAN JOURNAL OF MEDICINE, 1983, 74 (06): : 1092 - 1092
  • [8] PIPERACILLIN PLUS AMIKACIN VERSUS CEFOTAXIME PLUS AMIKACIN IN NEUTROPENIC AND FEVERISH PATIENTS WITH MALIGNANT HEMOPATHIES
    PAVONE, V
    SPECCHIA, G
    GUARINI, A
    CONIGLIO, M
    IACULLI, L
    GIRARDI, F
    COLUCCI, A
    LISO, V
    CHEMIOTERAPIA, 1988, 7 (05): : 330 - 335
  • [9] PIPERACILLIN TAZOBACTAM AMIKACIN VERSUS PIPERACILLIN AMIKACIN TEICOPLANIN IN THE EMPIRICAL-TREATMENT OF NEUTROPENIC PATIENTS
    MICOZZI, A
    NUCCI, M
    VENDITTI, M
    GENTILE, G
    GIRMENIA, C
    MELONI, G
    MARTINO, P
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (01) : 1 - 8
  • [10] AMIKACIN ONCE DAILY PLUS METRONIDAZOLE VERSUS AMIKACIN TWICE DAILY PLUS METRONIDAZOLE IN COLORECTAL SURGERY
    DACOSTA, PM
    KAUFMAN, L
    HEPATO-GASTROENTEROLOGY, 1992, 39 (04) : 350 - 354
12345